[ad_1]
Pfizer logo of the American pharmaceutical company. yunhap news
On the 20th (local time), US pharmaceutical company Pfizer and Germany’s Bioentech applied for the emergency use of a new vaccine against coronavirus infection (Corona 19) jointly developed by the US Food and Drug Administration (FDA). . It plans to produce up to 50 million doses by this year and 1.3 billion doses by the end of next year.
The two companies said on the day that “the vaccine may be available to high-risk populations in the United States by the middle or end of next month” and “we will be ready to distribute the vaccine within hours of approval.” According to the Associated Press, emergency use approval is a temporary measure to increase drug use in the event of a public health crisis, and approval requirements are relatively less stringent than formal procedures. It is reported that the FDA has tentatively held a meeting to discuss vaccine-related issues on 8-10 next month.
.
[ad_2]
Source link
